<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40938670</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Loop Diuretic Dose Intensification versus Adjuvant Thiazide for Diuretic Resistance in Acute Heart Failure: Mechanistic Randomized Controlled Trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.0000000887</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal therapy for loop diuretic resistance may differ if caused by resistance at the site of action in the loop of Henle (DR-Loop) vs. compensatory distal reabsorption (DR-Distal). The study primarily aimed to compare diuretic strategies and explore if targeting the underlying diuretic resistance mechanism could optimize diuretic response.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients hospitalized with heart failure and diuretic resistance (6-hour cumulative natriuresis &lt;100 mmol after IV loop diuretic) were randomized 1:1 to 1) 2.5X IV loop dose intensification or 2) IV chlorothiazide addition to the same loop diuretic. The primary trial outcome was the increase in 6-hour natriuresis between strategies. Exploratory analyses of diuretic resistance mechanism were performed. Diuretic resistance mechanisms were categorized using the fractional excretion of lithium (FELi), a metric evaluating sodium exit from the loop of Henle. DR-Loop was defined as a loop diuretic induced increase in FELi below the median and DR-Distal as an increase in FELi above the median at the screening visit.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients (mean age 68 &#xb1;12 years, 40% women) were randomized to loop dose intensification (N=51) or adjuvant thiazide (N=52). The primary outcome of increase in 6-hour natriuresis improved significantly with both strategies. However, chlorothiazide addition produced a significantly larger improvement in 6-hour natriuresis [107 mmol increase (95% CI 81, 132)] compared to loop augmentation [49 mmol increase (95% CI 31, 66)] (treatment effect 58 mmol [95% CI 27, 89]; P&lt;0.001). Paradoxically, loop intensification augmented natriuresis less in patients with DR-Loop compared to DR-Distal (27&#xb1;39 mmol vs 75&#xb1;77 mmol, respectively, P=0.004), and adjuvant thiazide did not increase natriuresis more in patients with DR-Distal versus DR-Loop (92&#xb1;71 mmol vs 105&#xb1;86 mmol, respectively, P=0.54).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Strategies of loop dose intensification and adjuvant thiazide both improved diuretic response, with a significantly larger augmentation of natriuresis with adjuvant thiazide. The underlying diuretic resistance mechanism did not identify a preferential response to either therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Veena S</ForeName><Initials>VS</Initials><Identifier Source="ORCID">0000-0002-1623-3445</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Zachary L</ForeName><Initials>ZL</Initials><Identifier Source="ORCID">0000-0002-4919-0146</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy Practice, Lipscomb University College of Pharmacy, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivey-Miranda</LastName><ForeName>Juan B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital de Cardiologia, Instituto Mexicano del Seguro Social, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Villagomez</LastName><ForeName>Julieta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Mastache</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7422-3480</Identifier><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maulion</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2510-4266</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellumkonda</LastName><ForeName>Lavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5733-949</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>F Perry</ForeName><Initials>FP</Initials><Identifier Source="ORCID">0000-0002-2633-2412</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and translational research accelerator, Yale University School of Medicine, New Haven, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shilpak</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-9559-204</Identifier><AffiliationInfo><Affiliation>Kidney Health Research Collaborative, Department of Medicine, University of California - San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estrella</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-8902-9576</Identifier><AffiliationInfo><Affiliation>Kidney Health Research Collaborative, Department of Medicine, University of California - San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welling</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0719-8705</Identifier><AffiliationInfo><Affiliation>Departments of Medicine and Physiology, John Hopkins School of Medicine, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcox</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-0943-1037</Identifier><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension Center, Georgetown University, Washington D.C.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellison</LastName><ForeName>David H</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0003-2915-265</Identifier><AffiliationInfo><Affiliation>Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forbush</LastName><ForeName>Biff</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Testani</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>12</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40938670</ArticleId><ArticleId IdType="doi">10.1681/ASN.0000000887</ArticleId><ArticleId IdType="pii">00001751-990000000-00772</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>